Share this post: ×

RECORDING: Swallowing Problems in Neurologic Disease: Why isn’t there a pill for that yet?

Swallowing Problems in Neurologic Disease: Why isn’t there a pill for that yet?

By Michelle Ciucci, PhD, CCC-SLP

Originally Broadcast on Monday, June 13 at 4pm Pacific

TAD Talk Description:

Neurologic disease is often distinguished by general characteristics, which can be take the focus off of other important symptoms. For example, people think of Parkinson disease as a ‘movement disorder’ or Alzheimer’s disease as ‘dementia’ that affects memory. However, these complex conditions affect multiple systems in the brain and body, and difficulty swallowing is often one of the first symptoms to manifest. For this T.A.D. Talk, we will break down the when/how/why these diseases may cause swallowing issues, what to look for, and how to get help.

Meet the Presenter: Michelle R. Ciucci, PhD, CCC-SLP

Michelle R. Ciucci, PhD, CCC-SLP is a speech-language pathologist and neuroscientist. She is a Professor of Communication Sciences & Disorders and Surgery/Otolaryngology Head & Neck Surgery at the University of Wisconsin-Madison. She is Associate Chair of the Department of Communication Sciences and Disorders and is Director of the MS-SLP program. Her translational research program is focused on understanding central nervous system mechanisms for sensorimotor control of vocalization, speech, and swallowing in health and neurologic disease. She also advances the study and clinical care of swallowing dysfunction with a new tool, high resolution manometry. The overarching goal of this line of work is to improve diagnosis and treatment of swallowing disorders with objective physiologic measures. She is a Board Member of the National Foundation of Swallowing Disorders. Professor Ciucci has authored over 65 peer-reviewed scientific journal articles and has been funded by the National Institutes of Health, Howard Hughes Medical Foundation, ASHA Foundation, and Michael J. Fox Foundation. As a clinician, Dr. Ciucci appreciates the clinical implications of her basic science findings with the goal of translating the work to conduct human clinical trials.

CEUs: No ASHA CEUs are offered for this webinar.

Cost: FREE. This webinar has been made free to all registrants. We recognize the financial hardship that is impacting many people due to the pandemic. As a non-profit, we feel this too. If you would like to make a donation, please visit our Donation Page.

The NFOSD wants to thank Bracco Diagnostics for their unrestricted educational grant.

The NFOSD TAD Talk Webinar Series is funded by an unrestricted educational grant provided by Bracco Diagnostics.